"Analysis.group","Analysis.number","Analysis.name","Subgroup","Applicability","Study","Study.year","GIV.Mean","GIV.SE","Experimental.mean","Experimental.SD","Experimental.cases","Experimental.N","Control.mean","Control.SD","Control.cases","Control.N","O.E","Variance","Weight","Mean","CI.start","CI.end","Footnotes","Bias.arising.from.the.randomization.process.judgement","Bias.arising.from.the.randomization.process.support","Bias.due.to.deviations.from.intended.interventions.judgement","Bias.due.to.deviations.from.intended.interventions.support","Bias.due.to.missing.outcome.data.judgement","Bias.due.to.missing.outcome.data.support","Bias.in.measurement.of.the.outcome.judgement","Bias.in.measurement.of.the.outcome.support","Bias.in.selection.of.the.reported.result.judgement","Bias.in.selection.of.the.reported.result.support","Overall.bias.judgement","Overall.bias.support","review.url","review.doi","analysis_key","dataset_name","mismatch_type","direction_match","or_sig","rd_sig","log_or","rd","log_or_ci_lb","log_or_ci_ub","rd_ci_lb","rd_ci_ub","sparse_events","double_zero"
7,2,"Withdrawal due to adverse event","AZA versus placebo","SUBGROUP_AND_OVERALL","Hawthorne 1992",1992,0,0,0,0,0,38,0,0,0,39,0,0,47.535042,0,-0.049316,0.049316,"","Low risk","<p>Randomziation and distribuition of intervention centrally performed in hospital pharmacies. </p><p>Quote: ""Randomisation was performed in hospital pharmacies in blocks of four."" </p><p>Quote: ""Trial drugs or placebo were dispensed by the hospital pharmacies using separate randomisation schedules [...].""</p><p>Baseline characteristics do not suggest a problem with randomization. </p>","Low risk","<p>Participants unaware of received intervention. Blinding of trial personnel delivering intervention likely. Appropiate analysis. </p>","Some concerns","<p>Two patients of AZA group excluded. One of them could depend on its true value. Regarding small size of study, impact on outcome likely. </p>","Low risk","<p>Outcome assessors unaware of intervention received. </p>","Some concerns","<p>No information as protocol was unavailable. </p>","Some concerns","<p>Due to some concerns regarding missing outcome data and unavailability of protocol. </p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000478.pub5/full","10.1002/14651858.CD000478.pub5","2::overall","CD000478_pub5_data","significance_only",TRUE,FALSE,TRUE,0.469376506878793,0.0964145889662329,-0.291627289168017,1.2303803029256,0.00926373329538287,0.183565444637083,TRUE,TRUE
7,2,"Withdrawal due to adverse event","AZA versus placebo","SUBGROUP_AND_OVERALL","Sood 2000",2000,0,0,0,0,3,25,0,0,0,25,0,0,30.872117,0.12,-0.021416,0.261416,"","Some concerns","<p>Randomization by ""pseudorandom numbers generated by scientific calculator."" No information on concealment of allocation. Disease duration at baseline significantly higher in azathioprine group. </p>","Some concerns","<p>Patients blinded to the intervention. Quote: ""The drugs were provided by a single coordinator to the patients in identical blister packs.""</p><p>People delivering intervention unblinded. Quote: ""The treatment physician was aware of the drug treatment.""</p><p>Exclusion of five (two placebo, three azathioprine) patients due to documented reasons. Quote: ""Five patients were excluded because of noncompliance and violation of treatment protocol (use of other medication).""</p><p>Apporpiate analysis used. Quote: ""Clinical outcome was compared [...] on an intention-to-treat basis.""</p>","Some concerns","<p>Exclusion of five (two placebo, three azathioprine) patients due to noncompliance and violation of treatment protocol (use of other medication). Reasons for noncompliance were not provided. </p>","Low risk","<p>Outcome assessor aware of intervention received. Unlikely, knowledge of intervention received could have affected outcome assessment. </p>","Some concerns","<p>No information as protocol was unavailable. </p>","Some concerns","<p>Due to insufficient information on concealment of allocation and unavailable protocol. </p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000478.pub5/full","10.1002/14651858.CD000478.pub5","2::overall","CD000478_pub5_data","significance_only",TRUE,FALSE,TRUE,0.469376506878793,0.0964145889662329,-0.291627289168017,1.2303803029256,0.00926373329538287,0.183565444637083,TRUE,TRUE
7,2,"Withdrawal due to adverse event","AZA versus placebo","SUBGROUP_AND_OVERALL","Sood 2002",2002,0,0,0,0,0,17,0,0,0,18,0,0,21.592841,0,-0.104614,0.104614,"","Some concerns","<p>Randomization by ""pseudorandom numbers ranging from 0-1, generated by scientific calculator."" </p><p>No information on concealment of allocation.</p><p>Baseline characteristics do not suggest a problem with randomization.</p>","Low risk","<p>Participants unaware of intervention received. Trial personnel aware of intervention received. Appropiate analysis.</p><p>Quote: ""[...] identical matched placebo drugs [...]""<br>Quote: ""The drugs were provided by a single coordinator (V.K.) to the patients in identical blister packs.""</p>","Low risk","<p>Results for this outcome was available for all randomized patients. </p>","Low risk","<p>Outcome assessors unaware of intervention received. </p><p>Quote: ""[...] double-blind trial.""</p>","Some concerns","<p>No information as protocol was unavailable. </p>","Some concerns","<p>Due to no information on concealment of allocation and unavailabilitiy of protocol. </p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000478.pub5/full","10.1002/14651858.CD000478.pub5","2::overall","CD000478_pub5_data","significance_only",TRUE,FALSE,TRUE,0.469376506878793,0.0964145889662329,-0.291627289168017,1.2303803029256,0.00926373329538287,0.183565444637083,TRUE,TRUE
7,2,"Withdrawal due to adverse event","AZA versus cyclosporin","SUBGROUP_AND_OVERALL","Paraskeva 2000",2000,0,0,0,0,1,8,0,0,1,8,0,0,100,0,-0.324099,0.324099,"","Some concerns","<p>Quote: ""Sixteen patients were randomized to oral administration of either azathioprine or cyclosporin [...] .""</p><p>Quote: ""Both groups were comparable in demographic and disease characteristics.""</p><p>No information on concealment of allocation. </p>","High risk","<p>No information on blinding and analysis used. </p>","Low risk","<p>Results for this outcome available for all randomized participants. </p>","High risk","<p>No information on methods of outcome assessment. </p>","Some concerns","<p>No information as protocol was unavailable. </p>","High risk","<p>No information on blinding, outcome assessment, and used analysis.</p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000478.pub5/full","10.1002/14651858.CD000478.pub5","2::overall","CD000478_pub5_data","significance_only",TRUE,FALSE,TRUE,0.469376506878793,0.0964145889662329,-0.291627289168017,1.2303803029256,0.00926373329538287,0.183565444637083,TRUE,TRUE
7,2,"Withdrawal due to adverse event","6-MP versus GMA","SUBGROUP_AND_OVERALL","Sakuraba 2012",2012,0,0,0,0,1,11,0,0,0,10,0,0,100,0.090909,-0.133068,0.314886,"","Some concerns","<p>Computer generated randomization. Quote: ""The randomization was based on a computer generated scheme that assigned the eligible patient to the next randomization.""</p><p>No information on concealment of allocation.</p>","Low risk","<p>Both participants and trial personnel aware of the intervention received. Withdrawal consistent with standard care. Analysis appropiate. </p>","Low risk","<p>Results for this outcome was available for all randomized patients. </p>","Low risk","<p>Outcome assessor aware of intervention received. Unlikely, knowledge of intervention received could have effected outcome assessment. </p>","Some concerns","<p>No information as protocol was unavailable.</p>","Some concerns","<p>Due to insufficient information on concealment of allocation and unavailable protocol. </p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000478.pub5/full","10.1002/14651858.CD000478.pub5","2::overall","CD000478_pub5_data","significance_only",TRUE,FALSE,TRUE,0.469376506878793,0.0964145889662329,-0.291627289168017,1.2303803029256,0.00926373329538287,0.183565444637083,TRUE,TRUE
7,2,"Withdrawal due to adverse event","AZA vs L-AZA+ALLO","SUBGROUP_AND_OVERALL","Kiszka-Kanowitz 2022",2022,0,0,0,0,16,42,0,0,14,47,0,0,100,0.08308,-0.113551,0.279711,"Azathioprine versus low dose-azathioprine + allopurinol","Low risk","<p>Centralized, computer-based randomization. Quote: ""Patients were randomised using computer generated random numbers via a centralized randomisation service.""</p><p>Concealment of allocation in sealed envelopes. Quote: ""The allocation sequence was concealed in envelopes.""</p><p>Baseline characteristics do not suggest a problem with randomization.</p>","Low risk","<p>Both participants and trial personnel aware of intervention received. Analysis was appropiate. </p><p>Quote: ""We conducted our analyses based on the intention-to-treat principle including all patients randomised who received at least one dose of the allocated study drug.""</p>","Low risk","<p>Results for this outcome available for all randomized participants. </p>","Low risk","<p>Outcome assessor aware of intervention received. Unlikely, knowledge of intervention received could have effected outcome assessment. </p>","Low risk","<p>Prospectively registered protocol. Outcome reported as registered.</p>","Low risk","<p>Due to low risk of bias in all domains.</p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000478.pub5/full","10.1002/14651858.CD000478.pub5","2::overall","CD000478_pub5_data","significance_only",TRUE,FALSE,TRUE,0.469376506878793,0.0964145889662329,-0.291627289168017,1.2303803029256,0.00926373329538287,0.183565444637083,TRUE,TRUE
